Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis

Table 6 Factor analysis of the logistic regression model

Index		SE	Walds	P value	OR	95%CI
Age	0.551	0.225	5.997	0.007	1.735	1.116	2.697
Course of disease	0.494	0.240	4.237	0.048	1.639	1.024	2.623
BMI	0.381	0.211	3.261	0.094	1.464	0.968	2.213
FPG	0.307	0.184	2.784	0.116	1.359	0.948	1.950
HbA1c	0.502	0.316	2.524	0.131	1.652	0.889	3.069
Hypertension	0.484	0.408	1.407	0.248	1.623	0.729	3.610
Coronary heart disease	0.490	0.411	1.421	0.241	1.632	0.729	3.653
GLP-1	-0.616	0.277	4.945	0.039	0.540	0.314	0.930
MGP	-0.573	0.254	5.089	0.037	0.564	0.343	0.928
β-CTX	0.184	0.152	1.465	0.237	1.202	0.892	1.619
BALP	0.207	0.182	1.294	0.301	1.230	0.861	1.757
BGP	0.118	0.104	1.287	0.316	1.125	0.918	1.380

BMI: body mass index; FPG: Fasting plasma glucose; GLP-1: Glucagon-like peptide-1; MGP: Matrix Gla protein; BALP: Bone alkaline phosphatase; P1NP: Type 1 procollagen amino-terminal propeptide; BGP: Osteocalcin; β-CTX: Special sequence of carboxy-terminal peptide β of type 1 collagen.